UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Squamous Cell Carcinoma Antigen Isoforms in Serum from Cervical Cancer Patients

Tumor biology, 2006-01, Vol.27 (3), p.142-152

2006

Volltextzugriff (PDF)

Lymphvascular space involvement: an independent prognostic factor in endometrial cancer

Gynecologic oncology, 2005-03, Vol.96 (3), p.799-804

2005

Volltextzugriff (PDF)

The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer

British journal of cancer, 2008-07, Vol.99 (2), p.341-349

2008

Volltextzugriff (PDF)

Squamous Cell Carcinoma Antigen Isoforms in Serum from Cervical Cancer Patients

Tumor biology, 2006, Vol.27 (3), p.142-152

2006

Volltextzugriff (PDF)

Tamoxifen treatment and gynecologic side effects: a review

Obstetrics & Gynecology, 2001-05, Vol.97 (5), p.855-866

2001

Volltextzugriff (PDF)

Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpression

Journal of immunotherapy (1997), 2011-07, Vol.34 (6), p.516

2011

Volltextzugriff (PDF)

Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study

Gynecologic oncology, 2005-03, Vol.96 (3), p.705-713

2005

Volltextzugriff (PDF)

Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies

British journal of cancer, 2006-09, Vol.95 (5), p.627-633

2006

Volltextzugriff (PDF)

Preoperative Serum Squamous Cell Carcinoma Antigen Levels in Clinical Decision Making for Patients With Early-Stage Cervical Cancer

Journal of clinical oncology, 2005-03, Vol.23 (7), p.1455-1462

2005

Volltextzugriff (PDF)

Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy

British journal of cancer, 2002-05, Vol.86 (10), p.1546-1550

2002

Volltextzugriff (PDF)

MLH1 and MSH2 protein expression as a pre‐screening marker in hereditary and non‐hereditary endometrial hyperplasia and cancer

International journal of cancer, 2001-05, Vol.92 (3), p.398-403

2001

Volltextzugriff (PDF)

Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment

International journal of radiation oncology, biology, physics, 2002, Vol.52 (1), p.23-32

2002

Volltextzugriff (PDF)

Discrepancy between Ultrasonography and Hysteroscopy and Histology of Endometrium in Postmenopausal Breast Cancer Patients Using Tamoxifen

Gynecologic oncology, 1999-04, Vol.73 (1), p.21-26

1999

Volltextzugriff (PDF)

Ovarian cysts in women receiving tamoxifen for breast cancer

British Journal of Cancer, 1999-04, Vol.79 (11-12), p.1761-1764

1999

Volltextzugriff (PDF)

Fas and Fas ligand in cyst fluids, serum and tumors of patients with benign and (borderline) malignant ovarian tumors

International journal of oncology, 2005-02, Vol.26 (2), p.379

2005

Volltextzugriff (PDF)

Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium

Human pathology, 2002-03, Vol.33 (3), p.341-346

2002

Volltextzugriff (PDF)

Cervical carcinoma during pregnancy: outcome of planned delay in treatment

European journal of obstetrics & gynecology and reproductive biology, 1998-08, Vol.79 (2), p.153-157

1998

Volltextzugriff (PDF)

Rising serum values of β-subunit human chorionic gonadotrophin (hCG) in patients with progressive vulvar carcinomas

British journal of cancer, 1997, Vol.75 (8), p.1217-1218

1997

Volltextzugriff (PDF)

Serum and Cystic Fluid Levels of Soluble Interleukin-2 Receptor-Alpha in Patients with Epithelial Ovarian Tumors Are Correlated

Tumor biology, 1998, Vol.19 (3), p.160-166

1998

Volltextzugriff (PDF)

Cancer-Associated Antigen CA 195 in Patients with Mucinous Ovarian Tumours: A Comparative Analysis with CEA, TATI and CA 125 in Serum Specimens and Cyst Fluids

Tumor biology, 1993, Vol.14 (2), p.105-115

1993

Volltextzugriff (PDF)

Cross-reactivity with normal antigens in commercial anti-CEA sera, used for immunohistology. The need for tissue controls and absorptions

American journal of clinical pathology, 1983-01, Vol.79 (1), p.25-31

1983

Volltextzugriff (PDF)

Raised serum squamous cell carcinoma antigen levels in malignant transformation of mature cystic ovarian teratoma

International journal of gynecological cancer, 1996, Vol.6 (1), p.76-79

1996

Volltextzugriff (PDF)

The role of the liver in the clearance of IgG immune complexes from the circulation

Cell biology international reports, 1983-01, Vol.7 (6), p.401-401

1983

Volltextzugriff (PDF)

Serum CA 125, Carcinoembryonic Antigen, and CA 19-9 as Tumor Markers in Borderline Ovarian Tumors

Gynecologic oncology, 2000-07, Vol.78 (1), p.16-20

2000

Volltextzugriff (PDF)

Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma

Journal of clinical oncology, 1996-01, Vol.14 (1), p.111-118

1996

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Humans
(25)
Female
(24)
Biological And Medical Sciences
(22)
Medical Sciences
(21)
Oncology
(21)
Gynecology. Andrology. Obstetrics
(14)
Tumors
(14)
Female Genital Diseases
(13)
Middle Aged
(13)
Adult
(12)
Neoplasm Staging
(10)
Obstetrics & Gynecology
(9)
Prognosis
(9)
Aged
(8)
Aged, 80 And Over
(7)
Antigens, Neoplasm - Blood
(5)
Biomarkers, Tumor - Blood
(5)
Carcinoma, Squamous Cell - Pathology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Squamous Cell Carcinoma Antigen Isoforms in Serum from Cervical Cancer Patients

Lymphvascular space involvement: an independent prognostic factor in endometrial cancer

The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer

Squamous Cell Carcinoma Antigen Isoforms in Serum from Cervical Cancer Patients

Tamoxifen treatment and gynecologic side effects: a review

Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpression

Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study

Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies

Preoperative Serum Squamous Cell Carcinoma Antigen Levels in Clinical Decision Making for Patients With Early-Stage Cervical Cancer

Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy

MLH1 and MSH2 protein expression as a pre‐screening marker in hereditary and non‐hereditary endometrial hyperplasia and cancer

Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment

Discrepancy between Ultrasonography and Hysteroscopy and Histology of Endometrium in Postmenopausal Breast Cancer Patients Using Tamoxifen

Ovarian cysts in women receiving tamoxifen for breast cancer

Fas and Fas ligand in cyst fluids, serum and tumors of patients with benign and (borderline) malignant ovarian tumors

Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium

Cervical carcinoma during pregnancy: outcome of planned delay in treatment

Rising serum values of β-subunit human chorionic gonadotrophin (hCG) in patients with progressive vulvar carcinomas

Serum and Cystic Fluid Levels of Soluble Interleukin-2 Receptor-Alpha in Patients with Epithelial Ovarian Tumors Are Correlated

Cancer-Associated Antigen CA 195 in Patients with Mucinous Ovarian Tumours: A Comparative Analysis with CEA, TATI and CA 125 in Serum Specimens and Cyst Fluids

Cross-reactivity with normal antigens in commercial anti-CEA sera, used for immunohistology. The need for tissue controls and absorptions

Raised serum squamous cell carcinoma antigen levels in malignant transformation of mature cystic ovarian teratoma

The role of the liver in the clearance of IgG immune complexes from the circulation

Serum CA 125, Carcinoembryonic Antigen, and CA 19-9 as Tumor Markers in Borderline Ovarian Tumors

Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma

Suchergebnisse filtern